Immunoglobulin G4 Related-Disease: A Rare Presentation With Secondary Hypereosinophilic Syndrome and Eosinophilic Ascites.

Autoimmune pancreatitis Eosinophilic ascites Hypereosinophilic syndrome IgG4 related-disease Severe eosinophilia

Journal

Journal of medical cases
ISSN: 1923-4155
Titre abrégé: J Med Cases
Pays: Canada
ID NLM: 101551824

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 12 12 2020
accepted: 19 12 2020
entrez: 26 8 2021
pubmed: 27 8 2021
medline: 27 8 2021
Statut: ppublish

Résumé

Immunoglobulin G4 related-disease (IgG4-RD) is a multisystemic immune-mediated fibroinflammatory disease, with a strong predilection for salivary and lacrimal glands, pancreas, biliary tree, lungs, kidneys, aorta, and retroperitoneum. In the case of pancreatic involvement, it manifests as autoimmune pancreatitis. Patients with IgG4-RD usually have mild to moderate eosinophilia in the peripheral blood, however, they may present a secondary hypereosinophilic syndrome (HES). Although there are cases described with severe eosinophilia (> 5,000/µL), the 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-RD considers peripheral eosinophilia above 3,000/µL as an exclusion criterion, although stating that assessment for the presence of exclusion criteria should be individualized depending on a patient's clinical scenario. Here, we describe the clinical case of a 30-year-old woman who presented with chronic diarrhea and abdominal pain. The diagnostic workup revealed eosinophilic ascites, severe peripheral blood eosinophilia (> 5,000/µL), IgG4 elevation (> 2 × upper normal limit), and also diffuse swelling in the body and pancreatic tail (computed tomography (CT) scan). There was a prompt response to corticosteroid therapy with clinical resolution and continued remission under therapy. The patient was diagnosed with IgG4-RD with secondary HES, explaining the gastrointestinal tract and peritoneum damage in the form of enterocolitis and ascites. Exclusion of alternative diagnosis was made.

Identifiants

pubmed: 34434439
doi: 10.14740/jmc3634
pmc: PMC8383578
doi:

Types de publication

Case Reports

Langues

eng

Pagination

107-111

Informations de copyright

Copyright 2021, Serpa Pinto et al.

Déclaration de conflit d'intérêts

None to declare.

Références

Gastroenterol Clin North Am. 2019 Jun;48(2):291-305
pubmed: 31046976
Mod Pathol. 2012 Sep;25(9):1181-92
pubmed: 22596100
Exp Ther Med. 2018 Mar;15(3):2739-2748
pubmed: 29456677
Clin Gastroenterol Hepatol. 2009 Oct;7(10):1097-103
pubmed: 19410017
Blood. 2015 Aug 27;126(9):1069-77
pubmed: 25964669
Ann Rheum Dis. 2020 Jan;79(1):77-87
pubmed: 31796497
Haematologica. 2019 Mar;104(3):444-455
pubmed: 30705099
Eur J Haematol. 2017 Apr;98(4):378-387
pubmed: 28005278

Auteurs

Luisa Serpa Pinto (L)

Internal Medicine Department, Centro Hospitalar e Universitario do Porto, Porto, Portugal.

Nuno Jorge Lamas (NJ)

Anatomic Pathology Service, Pathology Department, Centro Hospitalar e Universitario do Porto, Porto, Portugal.
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
ICVS/3Bs PT Government Associate Laboratory, Braga/Guimaraes, Portugal.

Ana Campar (A)

Clinical Immunology Unit, Centro Hospitalar e Universitario do Porto, Porto, Portugal.

Alvaro Ferreira (A)

Internal Medicine Department, Centro Hospitalar e Universitario do Porto, Porto, Portugal.
Clinical Immunology Unit, Centro Hospitalar e Universitario do Porto, Porto, Portugal.

Ana Rita Cruz (AR)

Internal Medicine Department, Centro Hospitalar e Universitario do Porto, Porto, Portugal.

Classifications MeSH